4Jang IK,Tearney G,Bouma B.Visualization of tissue prolapse between coronary stent struts by optical coherence tomography:comparison with intravascular ultrasound.Circulation,2001,104:2754.
5Yabushita H,Bouma BE,Houser SL,et al.Characterization of human atherosclerosis by optical coherence tomography.Circulation,2002,106:1640-1645.
6Patwari P,Weissman NJ,Boppart SA,et al.Assessment of coronary plaque with optical coherence tomography and high-frequency ultrasound.Am J Cardiol,2000,85:641-644.
7Jang IK,Tearney GJ,MacNeill B,et al.In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography.Circulation,2005,111:1551-1555.
8Jang IK,Bouma BE,Kang DH,et al.Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography:comparison with intravascular ultrasound.J Am Coll Cardiol,2002,39:604-609.
9Bouma BE,Tearney GJ,Yabushita H,et al.Evaluation of intracoronary stenting by intravascular optical coherence tomography.Heart,2003,89:317-320.
10Jang IK,Tearney G, Bouma B. Visualization of tissue prolaps between coronary stent struts by optical coherence tomography: comparison with intravascular ultrasound. Circulation ,2001,104:2754.
1Awata M, Kotani J, Uematsu M, et al. Serial angioscopic evidence of incomplete neointimal coverage after sirolimuseluting stent implantation: comparison with bare metal stents[J]. Circulation, 2007, 116 (8): 910-916.
2Chen BX, Ma FY, Luo W, et al. Neointimal coverage of bare metal and sirolimus-eluting stents evaluated with optical coherence tomography [ J ]. Heart, 2008, 94 (5) : 566- 570.
3Xie Y, Takano M, Murakami D, et al Comparison of neointimal coverage by optical coherence tomography of a sirolimus-eluting stent versus a bare-metal stent three months after implantation [ J ]. Am J Cardiol, 2008, 102 (1) : 27-31.
4Gorog DA, Douglas H, Ahmed N, et al. Coronary angioplasty enhances platelet reactivity through yon Willebrand factor release [J]. Heart, 2003, 89 (3) : 329-330.
5Vargova K, Toth-Zsamboki E, Beres B J, et al. Circulating endothelial cell count, plasma vWF and soluble ICAM-1 levels following primary or elective percutaneous coronary intervention [ J ]. Atherosclerosis, 2008, 198 ( 2 ) : 366-372.
6Shin DI, Kim PJ, Seung KB, et al. Drug eluting s ient implantation could be associated with long term coronary endothelial dysfunction [ J ]. Int Heart J, 2007, 48 ( 5 ) : 553-567.
7Poerner TC, Otto S, Gassdorf J, et al. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6- months after implantation of a coronary everolimus-eiuting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon ( OCTOPUS Trial ) : rationale, design and methods [ J ]. Eur Intervention, 2011, Suppl K : K93-99.
8Boos C J, Balakrishnan B, Jessani S, et al. Effects of percutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage/ dysfunction[J]. Chest, 2007, 132 (6) : 1 920 -926.
